These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7633015)

  • 41. [Effect of ranitidine on the pharmacokinetics of theophylline in patients with obstructive pulmonary disease].
    Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V; Bozović M
    Glas Srp Akad Nauka Med; 1991; (41):45-52. PubMed ID: 1916446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between the fluoroquinolones and the bronchodilator theophylline.
    Wijnands WJ; Vree TB
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of norfloxacin on theophylline disposition: a comparison with other fluoroquinolones.
    Davis JD; Aarons L; Houston JB
    Pharm Res; 1995 Feb; 12(2):257-62. PubMed ID: 7784342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interaction.
    Pollak PT; Slayter KL
    Pharmacotherapy; 1997; 17(4):827-9. PubMed ID: 9250566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.
    Mizuki Y; Fujiwara I; Yamaguchi T
    J Antimicrob Chemother; 1996 May; 37 Suppl A():41-55. PubMed ID: 8737124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ranitidine on theophylline metabolism in healthy Koreans living in China.
    Kehoe WA; Sands CD; Long LF; Lan HH; Harralson AF; Shin HT; Jones DW
    Ann Pharmacother; 1996 Feb; 30(2):133-7. PubMed ID: 8835044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.
    Cesana M; Broccali G; Imbimbo BP; Crema A
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):133-8. PubMed ID: 2071262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM; Hudson SA; Jefferson GC
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theophylline in asthma and COPD: changing perspectives and controversies.
    Poe RH; Utell MJ
    Geriatrics; 1991 Apr; 46(4):55-6, 61-5. PubMed ID: 2010095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
    Robson RA; Begg EJ; Atkinson HC; Saunders DA; Frampton CM
    Br J Clin Pharmacol; 1990 Apr; 29(4):491-3. PubMed ID: 2328197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
    J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
    Lacarelle B; Blin O; Audebert C; Auquier P; Karsenty H; Horriere F; Durand A
    Eur J Clin Pharmacol; 1994; 46(5):477-8. PubMed ID: 7957547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of clinafloxacin after single and multiple doses.
    Randinitis EJ; Brodfuehrer JI; Eiseman I; Vassos AB
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2529-35. PubMed ID: 11502525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Serum theophylline concentrations in patients with chronic obstructive lung diseases: a comparison of 2 methods].
    Voshaar T; Schweisfurth H; Schöttes C; Prinsen J; Koch HP
    Pneumologie; 1990 Feb; 44 Suppl 1():283-4. PubMed ID: 2195516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of pentoxifylline on steady-state theophylline serum concentrations from sustained-release formulations.
    Ellison MJ; Horner RD; Willis SE; Cummings DM
    Pharmacotherapy; 1990; 10(6):383-6. PubMed ID: 2287557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
    Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.